Latest Breaking News On - பிரத்தியேகமான வளர்ச்சி கூட்டாளர்கள் - Page 1 : comparemela.com

CHARLOTTESVILLE, Va., July 07, 2021 (GLOBE NEWSWIRE) Adial Pharmaceuticals, Inc. ( ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that the Company has entered into Securities Purchase Agreements (“SPAs”) for the private placement of 1,666,667 shares of common stock at a price of $3.00 per share (the “Shares”) for total proceeds of $5,000,000. The private placement was led by Bespoke Growth Partners, Inc., which subscribed for $2,500,000. Other investors include Keystone Capital Partners LLC and Richard Gilliam, founder of Cumberland Resources (collectively, “Investors”). Brookline Capital Markets, a division of Arcadia Securities, LLC, acted as an advisor on the transaction.

Eteläuomen läiRichard gilliamDavid waldman natalya rudmanAdial pharmaceuticals incUniversity of helsinkiCrescendo communicationsArcadia securitiesBespoke growth partners incExchange commissionAdial pharmaceuticalsKeystone capital partnersSecurities purchase agreementsBespoke growth partnersCumberland resourcesBrookline capital marketsAlcohol use disorder